All data are based on the daily closing price as of June 27, 2025
s
Seegene
096530.KQ
24.29 USD
-0.81
-3.23%
Overview
Last close
24.29 usd
Market cap
1.12B usd
52 week high
25.81 usd
52 week low
14.21 usd
Target price
31.66 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
3.5137
Price/Book Value
1.5659
Enterprise Value
845.47M usd
EV/Revenue
2.6083
EV/EBITDA
12.1373
Key financials
Revenue TTM
324.14M usd
Gross Profit TTM
196.16M usd
EBITDA TTM
61.92M usd
Earnings per Share
N/A usd
Dividend
0.59 usd
Total assets
839.36M usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.